A new FDA bone graft warning has been issued, advising doctors to avoid off-label use of certain bone graft substitutes in patients with bone disorders, who are younger than 18 years old ─ this includes Medtronic’s Infuse bone graft. The FDA noted that these bone graft substitutes could cause serious... Read more »

Researchers from Kaiser Permanente have confirmed there is no way for doctors to spot uterine sarcoma before performing a laparoscopic hysterectomy or myomectomy with morcellation. As a result, morcellation may spread cancer throughout the abdomen. On December 11, the American Journal of Obstetrics and Gynecology published the report examining the... Read more »

Johns Hopkins researchers recently published information that may increase the number of women who experience complications from morcellation with hysterectomy procedures. The January issue of Obstetrics and & Gynecology details the accounts of three women who submitted to laparoscopic hysterectomy morcellation, ultimately resulting in benign uterine diseases rather than having... Read more »

Attorneys for both sides continue to engage in mediation to reach Stryker Rejuvenate hip settlements, so the thousands of pending cases don’t have to be tried individually in courts across the nation. More than 4,000 product liability cases are currently pending against the medical device manufacturer in state and federal... Read more »

Findings from two recent JAMA Internal Medicine studies may reveal some of the causes behind hip replacement problems and similar issues with other medical implants. Researchers discovered the U.S. Food and Drug Administration doesn’t always complete proper due diligence on medical devices. Each year, millions of patients receive medical implants,... Read more »

Proceedings for the first DePuy Pinnacle hip trial began on September 2 in Dallas, under the direction of U.S. District Judge Ed Kinkeade. This is the first trial involving allegations that the metal-on-metal hip implant poisoned patients, due to its defective design causing metal debris to enter into patients’ bloodstreams.... Read more »

A Medtronic INFUSE bone graft settlement was recently announced, with the medical technology company agreeing to pay $22 million to settle approximately 1,000 legal claims over the controversial spine surgery product. Medtronic is also setting an additional $140 million aside to fund an even larger number of expected claims. The... Read more »